(BANB) Bachem Holding - Ratings and Ratios

Bachem Holding AG, a global leader in peptide chemistry, specializes in the development, production, and supply of high-quality peptide active pharmaceutical ingredients (APIs) and intermediates. Serving pharmaceutical and biotechnology companies, Bachem supports all stages from research to commercialization. Their expertise extends to oligonucleotide APIs, catering to the growing demand for innovative therapies. Bachem offers a comprehensive suite of services, including process development, GMP production, and regulatory support, ensuring compliance with global standards. Headquartered in Bubendorf, Switzerland, since 1971, Bachem operates state-of-the-art facilities, emphasizing quality and reliability to meet the evolving needs of the pharmaceutical industry. Their global supply chain and extensive product portfolio underscore their commitment to advancing drug discovery and development.

Bachems services encompass project management, quality assurance, regulatory affairs, and analytical support, fostering long-term partnerships with clients. Their research-grade products and APIs are integral to various therapeutic areas, including oncology and infectious diseases. By integrating cutting-edge technologies and sustainable practices, Bachem maintains its position at the forefront of the peptide and oligonucleotide markets, driving innovation and efficiency in drug manufacturing.